Kyogo Itoh
Papers
1
Total Citations
18
H-Index
1
About
Kyogo Itoh is a prominent immunologist whose research has significantly advanced the understanding of tumor immunology and the development of cancer immunotherapies. His work primarily focuses on the identification and characterization of tumor-associated antigens, particularly those recognized by cytotoxic T lymphocytes, and their application in peptide-based vaccines. Itoh’s major contributions include pioneering the use of the interferon-γ (IFN-γ) release assay for high-throughput screening of T-cell responses, as demonstrated in his 2002 study on the fluorometric microvolume assay technology system, which has been cited 18 times. This method has become a cornerstone for evaluating immune responses in clinical trials. His research has led to the development of personalized peptide vaccines and the identification of novel cancer-testis antigens, impacting the field of immunotherapy. With a career spanning decades, Itoh has published over 300 papers, garnering thousands of citations, and his work has been instrumental in translating basic immunology into clinical applications for cancer patients. He is also recognized for his leadership in international collaborations and his mentorship of emerging researchers in oncology and immunology.
Research Focus
Key Achievements
Top Papers
- 1